Loading...

The Latest Innovations in the Drug Pipeline for Multiple Sclerosis

Several new medications are being investigated in late-phase studies for the treatment of patients with relapsing or progressive multiple sclerosis (MS). These agents represent a variety of mechanisms of action and provide not only lower relapse rates but also improvement in disabilities. The majori...

Full description

Saved in:
Bibliographic Details
Published in:Am Health Drug Benefits
Main Authors: Radick, Lea, Mehr, Stanton R.
Format: Artigo
Language:Inglês
Published: Engage Healthcare Communications, LLC 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4684635/
https://ncbi.nlm.nih.gov/pubmed/26702336
Tags: Add Tag
No Tags, Be the first to tag this record!